Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In

cstip : cstip-for-healthcare-providers

​​​​​​​​​​​​​​  Center for Sexually Transmitted Infection Prevention (CSTIP)  

Resources for Healthcare Providers

Young people ages 15 to 24 account for almost half of all cases of sexually transmitted infections (STIs). Health care providers can play a critical role in prevention by talking to patients about their sexual health; offering STI screening and treatment; and encouraging their patients to talk to their partners about prevention, screening and treatment. The resources here are designed to help you start those conversations and to link you to the latest screening and treatment guidelines.

CDC Treatment Guidelines

Provider Education & Training

Provider Tools

Healthcare providers MUST report STIs to their local
health department.

Maryland regulations require healthcare providers to report chlamydia, gonorrhea, and syphilis infections within one business day.  Reporting by laboratories does NOT nullify the healthcare provider’s obligation to report these diseases and conditions, nor does reporting by healthcare providers nullify the laboratory’s obligation to report.

To report a sexually transmitted notifiable disease, please complete both the general section of the DHMH 1140 morbidity report and the STI-specific section below it. The clinical and demographic information healthcare providers supply (which is normally unavailable from laboratories) enables the health department to better monitor disease trends and halt further transmission.

If you have a patient who recently tested positive for syphilis, gonorrhea, or chlamydia infection, the state or local health department may contact your office for additional information. Such information may include, confirmatory test results or treatment type and date of administration, as part of assuring comprehensive prevention and case management for your clients and their respective partners.  

HIPAA and Disease Reporting

The HIPAA Privacy Rule permits physicians and other covered entities to disclose protected health information, without a patient's written authorization, to public health authorities who are legally authorized to receive such reports for the purpose of preventing or controlling disease. This includes conducting public health surveillance, investigations, or interventions.

For more about the privacy rule and public health see:


Intimate Partner Violence

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Updated 3/10/2014

 

STI HOT TOPICS

CDC STD Tx Guide mobile app

Doxycycline and Tetracycline Shortage Update

Updated Gonorrhea Treatment Regimens - August 2012 - CDC. 

Provider Alert - Syphilis

 

 

 
 

Annual Sexual and Reproductive Health Webinar Series:

The Intersection of Clinical and Public Health Practice: STI Management in the HIV-Infected Person

Khalil Ghanem, MD, PhD
(April 2, 2014)

STI Hot Topics: What's New In Sexually Transmitted Infections?
John G. Bartlett, MD
(April 17, 2013)

Sex and the Superbug:
Next Steps in Dealing with Multi-Drug Resistant Gonorrhea in Maryland,
Khalil Ghanem, MD, PhD and
Jafar H. Razeq, PhD
(October 4, 2012)

Sexual and Reproductive Health Care: What About the Young Male? 
Arik V. Marcell,, MD, MPH

(April, 2012)

Syphilis in Maryland:
Populations at Risk
 
Anne Marie Rompalo, MD, ScM

(April, 2011)

Gonorrhea and the Fading Treatment Frontier 
Anne Marie Rompalo, MD, ScM

(April, 2010)

 

 

 

 

 

 Updated 7/16/2014